Sanquin Blood Supply Foundation:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Sanquin Blood Supply Foundation - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7097
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:15
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オランダ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Sanquin Blood Supply Foundation (Sanquin) is a provider of blood bank and diagnostic services, plasma derived products, tissues and cells and reagents. It offers blood-related lab tests for hospitals, blood banks, obstetricians practices, pharmaceutical companies, insurance organizations, and various other institutes. The organization’s plasma derived products cater to various immunology disorders, and blood clotting disorders. Sanquin also conducts research to discover and develop new solutions for medical problems in the areas of transfusion medicine, hematology and immunology. It conducts research in collaboration with academic and research centers in the Netherlands and other countries. The organization has subsidiaries in Finland, Belgium, and the Netherlands. Sanquin is headquartered in Amsterdam, the Netherlands.

Sanquin Blood Supply Foundation – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Sanquin Blood Supply Foundation, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Sanquin Blood Supply Foundation, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Sanquin Blood Supply Foundation, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Sanquin Blood Supply Foundation, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Sanquin Blood Supply Foundation, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Sanquin Blood Supply Foundation, Medical Equipment, Deal Details 10
Partnerships 10
BioLegend Enters into Licensing Agreement with Sanquin Blood Supply Foundation 10
Sanquin Blood Supply Enters Into Partnership with Okklo Life Sciences 11
IBL International Enters Into Distribution Agreement With Sanquin Blood Supply Foundation 12
Sanquin Blood Supply Foundation – Key Employees 13
Sanquin Blood Supply Foundation – Locations And Subsidiaries 14
Head Office 14
Other Locations & Subsidiaries 14
Appendix 15
Methodology 15
About GlobalData 15
Contact Us 15
Disclaimer 15

List of Tables
Sanquin Blood Supply Foundation, Medical Equipment, Key Facts, 2016 2
Sanquin Blood Supply Foundation, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Sanquin Blood Supply Foundation, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Sanquin Blood Supply Foundation, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Sanquin Blood Supply Foundation, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Sanquin Blood Supply Foundation, Deals By Market, 2012 to YTD 2018 8
Sanquin Blood Supply Foundation, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
BioLegend Enters into Licensing Agreement with Sanquin Blood Supply Foundation 10
Sanquin Blood Supply Enters Into Partnership with Okklo Life Sciences 11
IBL International Enters Into Distribution Agreement With Sanquin Blood Supply Foundation 12
Sanquin Blood Supply Foundation, Key Employees 13
Sanquin Blood Supply Foundation, Subsidiaries 14

List of Figures
Sanquin Blood Supply Foundation, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Sanquin Blood Supply Foundation, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Sanquin Blood Supply Foundation, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Sanquin Blood Supply Foundation, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Sanquin Blood Supply Foundation, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Sanquin Blood Supply Foundation, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Sanquin Blood Supply Foundation, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Sanquin Blood Supply Foundation, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Sanquin Blood Supply Foundation:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Geron Corp (GERN):企業の財務・戦略的SWOT分析
    Geron Corp (GERN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • CTD Holdings Inc (CTDH):製薬・医療:M&Aディール及び事業提携情報
    Summary CTD Holdings Inc (CTDH), formerly Cyclodextrin Technologies Development Inc is a biotechnology company that develops, manufactures and distributes cyclodextrins products. The company’s products include aquaplex, trappsol and trappsol cyclo. It provides trappsol cyclo, which is a hydroxypropy …
  • DTE Energy Co (DTE):企業の財務・戦略的SWOT分析
    DTE Energy Co (DTE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Barnes & Noble Education Inc (BNED):企業の財務・戦略的SWOT分析
    Barnes & Noble Education Inc (BNED) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Centrotec Sustainable AG (CEV):企業の財務・戦略的SWOT分析
    Summary Centrotec Sustainable AG (Centrotec) is an energy company that provides energy saving systems. The company provides products such as medical technology plastics, climate systems, gas flue systems and engineering plastics, among others. It also offers ventilation with heat recovery, heating s …
  • Endo International plc:企業の戦略・SWOT・財務情報
    Endo International plc - Strategy, SWOT and Corporate Finance Report Summary Endo International plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Consolidated Edison Company of New York, Inc.:発電所・企業SWOT分析
    Consolidated Edison Company of New York, Inc. - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, in …
  • Implants International Ltd:企業の製品パイプライン分析
    Summary Implants International Ltd (Implants International) is a medical device company that manufactures, designs, and develops orthopedic implants, bio-engineering, and other products for the healthcare sector. The company’s products include revision systems, hip stems, hip stem ancillaries, aceta …
  • Carisma Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Carisma Therapeutics Inc (Carisma Therapeutics), formerly CARMA Therapeutics LLC, is a biotechnology company with focus on the discovery and development of macrophage-based immunotherapeutics for the treatment of cancer. The company exploits its proprietary CAR-macrophage platform to provide …
  • Mercy:企業の戦略的SWOT分析
    Mercy - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This u …
  • Reata Pharmaceuticals Inc (RETA):企業の財務・戦略的SWOT分析
    Summary Reata Pharmaceuticals Inc (Reata) is a clinical-stage biopharmaceutical company that develops innovative medicines for the treatment of serious and life-threatening diseases. The company’s clinical candidates include bardoxolone methyl and omaveloxolone, which target Nrf2, a transcription fa …
  • RegenxBio Inc (RGNX):製薬・医療:M&Aディール及び事業提携情報
    Summary RegenxBio Inc (RegenxBio), formerly ReGenX Biosciences LLC is a provider of therapeutics for various diseases. The company develops, commercializes and licenses recombinant adeno-associated virus (AAV) gene therapy. Its products include AAV plasmids, AAV vector reporter systems and custom AA …
  • SonarMed Inc:医療機器:M&Aディール及び事業提携情報
    Summary SonarMed Inc (SonarMed) is a medical device company that develops endotrachael systems used for the inhalation and ventilation assistance patients. The company offers products such as artificial respiratory, endotrachael tubes, biomedical acoustics, SonarMed Airwave, medical devices, disposa …
  • Societe Electrique de l’Our SA:企業の戦略的SWOT分析
    Societe Electrique de l'Our SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Ausenco Ltd:企業の戦略・SWOT・財務情報
    Ausenco Ltd - Strategy, SWOT and Corporate Finance Report Summary Ausenco Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Dabur India Limited:戦略・SWOT・企業財務分析
    Dabur India Limited - Strategy, SWOT and Corporate Finance Report Summary Dabur India Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Petroleos Mexicanos:石油・ガス:M&Aディール及び事業提携情報
    Summary Petroleos Mexicanos (PEMEX) is a state-owned integrated oil and gas company. It operates across the value chain of oil and gas industry, from exploration and production to processing, logistics and marketing. PEMEX also produces and distributes a wide range of petrochemical products. The com …
  • Avnet, Inc.:戦略・SWOT・企業財務分析
    Avnet, Inc. - Strategy, SWOT and Corporate Finance Report Summary Avnet, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Uniper SE (UN01):企業の財務・戦略的SWOT分析
    Uniper SE (UN01) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Kane Biotech Inc (KNE):企業の財務・戦略的SWOT分析
    Summary Kane Biotech Inc (Kane Biotech) is a developer of pharmaceutical products that prevent and remove microbial biofilms. The company uses patent protected technology based on molecular mechanisms of biofilm formation and methods for finding compounds that inhibit or disrupt biofilms. It develop …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆